Tuberculosis News and Research

Latest Tuberculosis News and Research

Researchers discover novel treatments for psoriasis that are likely to cause fewer side effects

Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis.

28 Feb 2014

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Seattle BioMed today announced that Jason Beaubien, global health and development correspondent of National Public Radio (NPR), will deliver the keynote address at the Passport to Global Health Celebration on March 5.

28 Feb 2014

Vitamin A may play key role in combating TB, says study

Tuberculosis is a major global problem, affecting 2 billion people worldwide and causing an estimated 2 million deaths annually. Western countries are once again tackling the disease, with recent outbreaks in Los Angeles and London.

27 Feb 2014

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

27 Feb 2014

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Protein M is a cell surface protein from Mycoplasma Genitalium that binds to all human antibodies.

26 Feb 2014

Active ingredient in vinegar can effectively kill mycobacteria

The active ingredient in vinegar, acetic acid, can effectively kill mycobacteria, even highly drug-resistant Mycobacterium tuberculosis, an international team of researchers from Venezuela, France, and the US reports in mBio-, the online open-access journal of the American Society for Microbiology.

25 Feb 2014

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.

25 Feb 2014

Professor receives $17M NIH grant to support IMPAACT Network

Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded $17 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

20 Feb 2014

New research may provide insight on how dengue virus gains entry into cells

Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever.

18 Feb 2014

New drug patent may help overcome problems associated with MDR-TB

A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.

18 Feb 2014

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

Two new mechanisms open alternative approaches to antibiotics development

The first mechanism disrupts the arrangement of amino acids required for the cohesion of the protease subunits. As a result the protease breaks into two parts. The second acts directly on the core of the active center.

14 Feb 2014

Researchers examine whether spirituality has role to play in prevention of addictions

Spirituality is a central tenet of 12-step recovery programs like Alcoholics Anonymous. Its value, particularly regarding alcohol addiction, has been recognized by many health care practitioners as well.

13 Feb 2014

Drug used for treating breast cancer also kills fungal disease

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio-, the online open-access journal of the American Society for Microbiology (ASM.)

11 Feb 2014

Study: Rise of tuberculosis in Zimbabwe linked with widespread food shortage

The rise of tuberculosis (TB) in Zimbabwe during the socio-economic crisis of 2008-9 has been linked to widespread food shortage, according to a new study led by Canadian researchers from the University of Toronto Dalla Lana School of Public Health published in PLOS ONE.

6 Feb 2014

EGPAF expansion of HIV and AIDS treatment, prevention programs in six districts in Lesotho

The Elizabeth Glaser Pediatric AIDS Foundation is pleased to announce the expansion of its HIV and AIDS treatment and prevention programs in six districts in Lesotho.

4 Feb 2014

Vodka contributes to high death rates in Russia, new study confirms

The high and sharply fluctuating death rates in Russia are due mainly to alcohol, particularly vodka, a new prospective study of 151 000 adults confirms.

3 Feb 2014

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Only 1 in 10 people who need palliative care - that is medical care to relieve the pain, symptoms and stress of serious illness - is currently receiving it. This unmet need is mapped for the first time in the "Global atlas of palliative care at the end of life", published jointly by the WHO and the Worldwide Palliative Care Alliance.

29 Jan 2014

Researchers identify unique area of human brain associated with cognitive powers

Oxford University researchers have identified an area of the human brain that appears unlike anything in the brains of some of our closest relatives.

29 Jan 2014

Tuberculosis News and Research

Latest Tuberculosis News and Research

Researchers discover novel treatments for psoriasis that are likely to cause fewer side effects

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Vitamin A may play key role in combating TB, says study

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Active ingredient in vinegar can effectively kill mycobacteria

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Professor receives $17M NIH grant to support IMPAACT Network

New research may provide insight on how dengue virus gains entry into cells

New drug patent may help overcome problems associated with MDR-TB

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Two new mechanisms open alternative approaches to antibiotics development

Researchers examine whether spirituality has role to play in prevention of addictions

Drug used for treating breast cancer also kills fungal disease

Study: Rise of tuberculosis in Zimbabwe linked with widespread food shortage

EGPAF expansion of HIV and AIDS treatment, prevention programs in six districts in Lesotho

Vodka contributes to high death rates in Russia, new study confirms

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Researchers identify unique area of human brain associated with cognitive powers

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in